Status:
UNKNOWN
Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
COVID-19
Sars-CoV2
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
The objectives of the study, are to describe detection of SARS-CoV-2 in the semen of COVID-19 positive patients, the duration of positive semen and to investigate the impact on semen quality, thereby ...
Detailed Description
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a novel coronavirus reported in late December 2019 in Wuhan, China, has spread world-wide with over 1,000,000 coronavirus disease 2019 (CO...
Eligibility Criteria
Inclusion
- Male
- PCR on nasopharyngeal swab positive for SARS-CoV-2
- Age: ≥ 18y - ≤ 50y
- Signed informed consent
- When undergoing ART treatment: ICSI treatment
Exclusion
- Negative test of SARS-CoV-2 on nasopharyngeal swab sample
- History of immunosuppression
- Impossibility to deliver a semen sample at UZ Brussel on a weekly base
- When undergoing ART treatment: IVF treatment
Key Trial Info
Start Date :
August 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04391829
Start Date
August 31 2020
End Date
August 31 2021
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Belgium, 1090